Age serves as the silent architect of FIB-4’s precision in unveiling advanced hepatic fibrosis in MASLD with T2DM: Correspondence to letter to the editor on “Diagnostic accuracy of the fibrosis-4 index for advanced liver fibrosis in nonalcoholic fatty liver disease with type 2 diabetes: a systematic review and meta-analysis”

Bibliographic Details
Published in:	Clinical and Molecular Hepatology
Main Authors:	Ji Won Han, Dae Won Jun
Format:	Article
Language:	English
Published:	Korean Association for the Study of the Liver 2025-04-01
Subjects:	diabetes mellitus, type 2 metabolic dysfunction-associated steatotic liver disease age fibrosis-4 index
Online Access:	http://e-cmh.org/upload/pdf/cmh-2024-1160.pdf

Similar Items

Sequential Diagnostic Approach Using FIB-4 and ELF for Predicting Advanced Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease
by: Yeo-Wool Kang, et al.
Published: (2024-11-01)

Essential tools for assessing advanced fibrosis in metabolic dysfunction-associated steatotic liver disease: Editorial on “Optimal cut-offs of vibration-controlled transient elastography and magnetic resonance elastography in diagnosing advanced liver fibrosis in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis”
by: Won Sohn
Published: (2025-01-01)

Long-term exposure to air pollution and liver fibrosis in the elderly with MASLD
by: Yanqi Lan, et al.
Published: (2025-08-01)

Evaluation of MASLD Fibrosis, FIB-4 and APRI Score in MASLD Combined with T2DM and MACCEs Receiving SGLT2 Inhibitors Treatment
by: Liu H, et al.
Published: (2024-06-01)

Proposal of a Novel Serological Algorithm Combining FIB-4 and Serum M2BPGi for Advanced Fibrosis in Nonalcoholic Fatty Liver Disease
by: Sang Yi Moon, et al.
Published: (2024-03-01)

A potential age-independent MASLD-related liver fibrosis index based on metabolic profiling
by: Serena Zampieri, et al.
Published: (2025-09-01)

Liver fibrosis increases the risk of subclinical atherosclerosis in patients with MASLD: a cross-sectional and longitudinal study
by: Haoyu Zhang, et al.
Published: (2025-07-01)

The Relationship Between Non-Invasive Tests and Digital Pathology for Quantifying Liver Fibrosis in MASLD
by: Xiaodie Wei, et al.
Published: (2025-09-01)

Evaluation of Liver Fibrosis through Noninvasive Tests in Steatotic Liver Disease
by: Yuri Cho
Published: (2024-11-01)

The Appropriate Opportunity for Evaluating Liver Fibrosis by Using the FIB-4 Index in Patients with Nonalcoholic Fatty Liver Disease in Japan
by: Yuya Seko, et al.
Published: (2020-10-01)

Suboptimal reliability of FIB‐4 and NAFLD‐fibrosis scores for staging of liver fibrosis in general population
by: Rawi Hazzan, et al.
Published: (2024-02-01)

Comparative evaluation of APRI, FIB-4, HFS, and NFS: Scoring tools for liver fibrosis in a Mexican population with MASLD
by: B.A. Priego-Parra, et al.
Published: (2024-10-01)

Diagnostic accuracy of the Fibrosis-4 index for advanced liver fibrosis in nonalcoholic fatty liver disease with type 2 diabetes: A systematic review and meta-analysis
by: Ji Won Han, et al.
Published: (2024-09-01)

The fibrosis-4 index for advanced liver fibrosis in NAFLD with T2DM: Half a loaf is better than no bread
by: Zeyu Wang, et al.
Published: (2025-01-01)

Prevalence of advanced liver fibrosis in the general population of the Paris region according to FIB-4 score and liver risk score
by: Henri Tran, et al.
Published: (2025-07-01)

Assessing Liver Fibrosis Using the FIB4 Index in the Community Setting
by: Albert Blanco-Grau, et al.
Published: (2021-11-01)

Liver Fibrosis Index FIB‐4 Is Associated With Mortality in COVID‐19
by: Yijia Li, et al.
Published: (2021-03-01)

Towards unification of liver stiffness measurement cutoffs: Editorial on “Optimal cut-offs of vibration-controlled transient elastography and magnetic resonance elastography in diagnosing advanced liver fibrosis in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis”
by: Yangyue Zhang, et al.
Published: (2025-01-01)

Comparing FIB-4, VCTE, pSWE, 2D-SWE, and MRE Thresholds and Diagnostic Accuracies for Detecting Hepatic Fibrosis in Patients with MASLD: A Systematic Review and Meta-Analysis
by: Mitchell Patrick Wilson, et al.
Published: (2025-06-01)

Mild-moderate alcohol consumption and diabetes are associated with liver fibrosis in patients with biopsy-proven MASLD
by: Ang Huang, et al.
Published: (2024-07-01)

Both APRI and FIB‐4 could effectively evaluate liver fibrosis in liver transplantation recipients
by: Xiao‐han Fang, et al.
Published: (2022-12-01)

Association between Body Fat Distribution and Nonalcoholic Fatty Liver Disease/Fibrosis Based on Race/Ethnicity
by: Donghee Kim, et al.
Published: (2024-12-01)

Effect of liver biopsy size on MASLD fibrosis assessment by second-harmonic generation/two-photon excitation fluorescence microscopy
by: Daniel T. Field, et al.
Published: (2025-08-01)

Diagnostic Performance of Fibrosis‐4 Index, Nonalcoholic Fatty Liver Disease Fibrosis Score, AST‐To‐Platelet Ratio Index, and BARD Score Among Young and Older Adults for the Diagnosis of Advanced MASLD Fibrosis: A Retrospective Cohort Study
by: Frank Lin, et al.
Published: (2025-09-01)

FIB-4 and APRI scores for progressive liver fibrosis diagnosis in children with biliary atresia
by: Hongyu Lyu, et al.
Published: (2024-01-01)

The Effect of Type 2 Diabetes Mellitus and Obesity on FIB-4 Index Screening for Early Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease
by: ZHUO Lili, QU Huanjia, ZHANG Qiuling
Published: (2025-04-01)

Correspondence to editorial on “Optimal cut-offs of vibration-controlled transient elastography and magnetic resonance elastography in diagnosing advanced liver fibrosis in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis”
by: Young Eun Chon, et al.
Published: (2025-01-01)

Impact of hypertension on liver fibrosis in patients with metabolic dysfunction-associated fatty liver disease
by: Zhifeng Gao, et al.
Published: (2025-01-01)

Effect of luseogliflozin on liver fibrosis differs depending on alcohol consumption in patients with type 2 diabetes
by: Hiroyuki Ito, et al.
Published: (2025-06-01)

Prediction of Advanced Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease by Type IV Collagen 7S
by: Hiroshi Ishiba, et al.
Published: (2025-01-01)

Predictors of Significant Fibrosis Among People Living with HIV with Metabolic Dysfunction- Associated Steatotic Liver Disease
by: Thaninee Prasoppokakorn, et al.
Published: (2024-12-01)

Association of serum iron status with MASLD and liver fibrosis.
by: Wenying Guo, et al.
Published: (2025-01-01)

Liver Cell Mitophagy in Metabolic Dysfunction-Associated Steatotic Liver Disease and Liver Fibrosis
by: Jiaxin Chen, et al.
Published: (2024-06-01)

Serum folate associated with nonalcoholic fatty liver disease and advanced hepatic fibrosis
by: Hao-Kai Chen, et al.
Published: (2023-08-01)

Prevalence of steatotic liver disease and associated fibrosis in the general population: An epidemiological survey: Letter to the editor on “Epidemiology of metabolic dysfunction-associated steatotic liver disease”
by: Lin Guan, et al.
Published: (2025-04-01)

Impact of a high dietary fiber cereal meal intervention on the progression of liver fibrosis in T2DM with MASLD
by: Xi-Shuang Chen, et al.
Published: (2025-09-01)

The Portal Venous Pulsatility Index and Main Portal Vein Diameter as Surrogate Markers for Liver Fibrosis in Nonalcoholic Fatty Liver Disease and Metabolic-Dysfunction-Associated Steatotic Liver Disease
by: Jaejun Lee, et al.
Published: (2024-02-01)

The development of the pediatric NAFLD fibrosis score (PNFS) to predict the presence of advanced fibrosis in children with nonalcoholic fatty liver disease.
by: Naim Alkhouri, et al.
Published: (2014-01-01)

RISK FACTORS ASSOCIATED WITH ADVANCED LIVER FIBROSIS IN PATIENTS WITH MASLD AT A PRIVATE CLINIC IN PERU
by: Fernando Junior Contreras Vargas, et al.
Published: (2025-09-01)

Advanced liver fibrosis, but not MASLD, is associated with accelerated biological aging: a population-based study
by: Chengcheng Tong, et al.
Published: (2024-11-01)